Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The clinical relevance of multiple sclerosis genetics: from susceptibility to disease severity and progression.
Perioperative chemotherapy and stereotactic body radiotherapy versus perioperative chemotherapy alone in patients with high-risk, localised pancreatic cancer (MASTERPLAN): an open-label, phase 2, multicentre, randomised trial of the Australasian Gastro-In
Bacterial cellulose-sericin gold nanoparticle conduit functionalized with GDNF for peripheral nerve regeneration: An experimental sciatic nerve injury model in rats.
Mechanistic insights into age- and vascular-related microstructure differences in the corpus callosum using biophysical modeling of diffusion MRI.
Short term effect of repetitive transcranial magnetic stimulation of the medial sensorimotor cortex for neurogenic pelvic floor dysfunction in multiple sclerosis: a randomized, double blind, sham controlled trial.
Autoimmune comorbidity profiles in MOGAD and AQP4-NMOSD: a real-world evidence study of top 10 autoimmune disorders across the pre- and post-COVID-19 eras.
Real-world treatment in pediatric-onset multiple sclerosis: Data from the Swiss pediatric inflammatory brain disease cohort study.
Hemispheric lesion asymmetry - An overlooked variable in tDCS targeting for multiple sclerosis.
Altered Cortico-cerebellar effective connectivity of the Visuo-attentional system is associated with READ1 deletion in developmental dyslexia.
Editorial for "Multi-Parametric Phase-Cycled Balanced Steady-State Free Precession Brain Tissue Characterization in Relapsing-Remitting Multiple Sclerosis".
Multi-Parametric Phase-Cycled Balanced Steady-State Free Precession Brain Tissue Characterization in Relapsing-Remitting Multiple Sclerosis.
Precision Nanomedicine for Traumatic Neural Injury: Functional Paradigms and Translational Frameworks.
Single cell landscape of sex differences in the different courses of multiple sclerosis.
Hepatic Orosomucoid 2 aggravates demyelination and drives microglial DAM-like activation.
Spectrum, management, and outcomes of non-obstetric neurological disorders in pregnancy: a descriptive case series from a tertiary centre in India.
Clinical heterogeneity in chronic inflammatory demyelinating polyneuropathy: data-driven subtypes challenge current classification.
Serine protease inhibitor A3 is a soluble SIRPα ligand that suppresses inflammation and antitumor immunity.
Myelin oligodendrocyte glycoprotein antibody-associated isolated seizures in children: a retrospective single-center case series.
Cholesterol dysregulation and microglial NLRP3 inflammasome activation after ischemic stroke: implications for neuroinflammation and functional recovery.
Efgartigimod for acute attacks of brainstem MOGAD followed by mycophenolate mofetil maintenance: a case report.
Prediction of short-term and long-term responses to cladribine in relapsing-remitting multiple sclerosis: a Danish nationwide real-world study.
Determining the minimal important difference of EQ-5D-5 L utility values in CIDP patients using data from a large clinical trial.
DELPHI expert consensus-derived factors influencing the early use of monoclonal high-efficacy therapies in treatment-naïve patients with relapsing-remitting multiple sclerosis.
Risk of Inflammatory Bowel Disease After Anti-CD20 Treatment in Multiple Sclerosis.
The Balance Between Immune Activation and Tolerance in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorders and MOG Antibody-Associated Disease.

Pages